TOURMALINE BIO, INC.
CIK 0001827506
Revenue (TTM)
—
Q2 Aug 2025
Net Income (TTM)
−$83.73M
−73.8% YoY
Q2 Aug 2025
EPS Diluted (TTM)
−$3.25
+67.4% YoY
Q2 Aug 2025
Gross Margin
—
Q2 Aug 2025
Operating Margin
—
Q2 Aug 2025
Net Margin
—
Q2 Aug 2025
Free Cash Flow (TTM)
−$58.05M
Q2 Aug 2025
Cash
$31.42M
Q2 Aug 2025
Total Debt
—
Q2 Aug 2025
Shares Outstanding
25.69M sh
Q2 Aug 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.